The following lists various projects in whlich MCL was completelly or partially responsible for obtaining FDA approval, either for marketing or for clinical investigation.
-
First non-thermal contact lens disinfecting solutions
-
Novel polymer dry eye solution
-
First commercially available punctum plug
-
Numerous contact lens studies: developmental and clinical investigations of hydrophilic soft and high DK RGP lenses
-
Lactoplate ( lactoferrin assaly of lacrimal fluid)
-
Sulfur hexaflluoride and perfluoropropane for treatment of retinal detachments
-
Initial clinical studies of silicone oil for retinal detachments
-
Initial formulations and submission for the use of cyclsporine and the treament of dry eye conditions
-
Clinical study of calcium carbonate ointment for the supracutaneous treatment of dry eyes
-
First tandem scanning confocal microscope for clinical use
-
Dye lasers for ophthalmic use
-
Clinical linvestigation of cultured corneal endothelial cells for DLEK procedures.
